Meeting compliance obligations and tackling counterfeit drugs with serialization
Thu 23 Sep 2010 3pm UK, 4pm Europe, 10am USA Eastern
The World Health Organization (WHO) estimates that 10% of all medication worldwide is counterfeit, a figure which is driving both increased regulation and demand for improved technological responses to protect the pharmaceutical supply chain.
In this webinar we examine the EFPIA serialization pilot and consider the increasing role of ePedigree solutions to fulfil these ever increasing compliance obligations and to ensure that pharmaceutical brands are not exposed to damaging recall actions.
Join this webinar to learn:
- The results of the serialization pilot
- How serialization enables reliable product identification at any stage in the supply chain
- How serialization fulfils proof of origin regulations for pharmaceutical products
- How to overcome the technological challenges
- How such solution can be easily integrated into existing ERP systems
- The business case for adopting serialization
Speakers
Hans Bijl
Hans Bijl is Sr. Business Development Manager at Siemens\' Industrial Automation Competence Centre Life Science, based Antwerp, Belgium. Over the last decade, he has been working in various fields in the Life Science arena, both in sales & marketing related assignments as well as number of dedicated projects (e.g. PAT/QbD, Continuous Manufacturing and Secure Tracking and Tracing).
From 2006 to 2008 he spent 2 years in Shanghai, China, building the local subsidiary of the Life Science Competence Centre, where he was able to capture the opportunities, challenges and pitfalls of the world’s largest developing pharma region from within.
Since his return to Europe, one of the assignments he picked up again is, on behalf of the Industry Division of Siemens, the corporate initiative around Pharmaceutical Anti-Counterfeiting measures and Supply Chain security, including serialisation.Hans has been a regular speaker at various conferences (e.g. ISPE), both in Asia and Europe.
Juergen Manz
Juergen Manz, is Head of Solution for Tracking & Tracing for the pharmaceutical industry at Siemens IT Solutions and Services. Juergen has more than fifteen years of experience in logistics, distributions and supply chain in the pharmaceutical industry and other sectors. Prior, Juergen was head of the solution for logistic unit in Siemens. During this time period Juergen was responsible for the RFID setup at Siemens IT Solutions and Services. He was in charge of business development, service offering setup, prototyping, customer development and member of RFID main project steering comities. Juergen is responsible for the design and implementation of Siemens Track & Trace solutions to improve supply chain processes and security.
Juergen published the several article concerning RFID, logistics, supply chain tracking & tracing and serilization, co-authored the Siemens Whitepaper Serialization@Siemens and spoke at several conferences.
Dr. Wolfgang Scheiding
Dr. Wolfgang Scheiding is Vice President of the Siemens Market Development Board Pharma. In addition he is also head of the Industrial Automation & Drives Technology (IA&DT) Vertical Market Management Pharma (former Competence Center Pharma).
Dr. Wolfgang Scheiding has already more than 26 years experience in the pharmaceutical business, especially in engineering and validation.
He started his career in Hoechst AG, at that time one of the biggest companies in the global chemical and pharmaceutical business, where he became deputy head of engineering department of electrical instrumentation, automation and control. After the split of Hoechst AG, Dr. Scheiding joined Axiva GmbH & Co. KG where her became Vice President of the Pharmaceutical Business Unit. Since 2000 he is in charge of the pharmaceutical business within the Siemens AG.
Based on his extensive experience with the pharmaceutical industry he fully understands the requirements and is aware of the need for solutions that are especially designed to fulfill the unique demands of pharmaceutical manufacturing.
Company Profile
Siemens is a leading supplier to manufacturers in the Life Science Industry, with product and solution offerings in the area of automation (building and process), drives, electrical infrastructure, power distribution, fire, safety, logistics, and water systems.
In addition to a broad and innovative product portfolio, Siemens offers services and competencies from dedicated engineering services to a multidisciplinary optimization approach throughout bio and pharmaceutical manufacturing to address the key issues of the industry and improve their business. This covers not only state-of-the-art technology but also work on strategic, long-term and comprehensive concepts to benefit the customer’s business worldwide.
Siemens AG (Berlin and Munich) is a global powerhouse in electronics and electrical engineering, operating in the industry, energy and healthcare sectors. For over 160 years, the company has stood for technical achievements, innovation, quality, reliability and internationality. In addition, Siemens is the world’s biggest provider of ecofriendly technologies. Around €23 billion, or nearly one-third of the company’s revenue, is generated by green products and solutions. In fiscal 2009, ended on September 30, 2009, Siemens had revenue of €76.7 billion and net income of €2.5 billion. At the end of September 2009, the company had around 405,000 employees worldwide. Further information is available on the Internet at: www.siemens.com.
Media Partner
SecuringPharma.com is a free-to-access information service that covers the issues surrounding counterfeit medicines and supply chain security in the pharmaceutical industry. Our aim is to provide practical advice and market intelligence to help drug-makers keep up-to-date with developments in the field and define their own strategies to safeguard the supply chain, from raw materials right through to the patient.